Decreased stability of α2-macroglobulin purified from patients with multiple sclerosis

Acta Neurologica Scandinavica

Volumn 101, Issue 4, 2000, Pages 270-272

  Gunnarsson, M ^a   Stigbrand, T ^a   Jensen, P E H ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b Mental Health Services CPH   (Denmark)

Author keywords

Conformation; Multiple sclerosis; Proteinase inhibitor; 2 macroglobulin

Indexed keywords

ALPHA 2 MACROGLOBULIN; PROTEINASE; PROTEINASE INHIBITOR;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN PURIFICATION; PROTEIN STABILITY; BLOOD; CASE CONTROL STUDY; CHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING;

ADULT; ALPHA-MACROGLOBULINS; CASE-CONTROL STUDIES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; PROTEASE INHIBITORS; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 0033624702     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.101004270.x     Document Type: Article

References (22)

1. 1. Banik NL. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes. Crit Rev Neurobiol 1992;16:257-71.
2. 2. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 1995;11:245-68.
3. 3. Baig S, Olsson T, Jiang YP, Höjeberg B, Cruz M, Link H. Multiple sclerosis: Cells secreting antibodies against myelin-associated glycoprotein are present in CSF. Scand J Immunol 1991;33:73-9.
4. 4. Olsson T, Baig S, Höjeberg B, Link H. Anti myelin basic protein and anti myelin antibodies in multiple sclerosis. Ann Neurol 1990;27:132-6.
5. 5. Cossins JA, Clements JM, Ford J et al. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 1997;94:590-8.
6. 6. Cuzner ML, Davison AN, Rudge P. Proteolytic enzyme activity of blood leucocytes and cerebrospinal fluid in multiple sclerosis. Ann Neurol 1978;4:337-44.
7. 2-macroglobulin isolated from multiple sclerosis serum. Clin Chim Acta 1980;107:141-4.
8. 2-macroglobulin in multiple sclerosis. Eur Neurol 1981;20: 33-9.
9. 2-macroglobulin on mitogen induction of lymphocyte proliferation. Immunobiol 1985;169:339-45.
10. 2-macroglobulin from plasma of patients with chronic-progressive or relapsing-remitting multiple sclerosis. Clin Chim Acta 1992;211:27-36.
11. 11. Saso L, Valentini G, Leone MG et al. Changes in concanavalin A-reactive proteins in neurological disorders. J Clin Lab Anal 1999;13:158-65.
12. 2-macroglobulin and related thiol ester plasma proteins. In: Putnam FW, ed. The Plasma proteins (2nd edition). Orlando: Academic Press, 1987;5:191-291.
13. 2-macroglobulin with proteinases: characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J 1973;133:709-24.
14. 2-macroglobulin and pregnancy zone protein. Eur J Biochem 1992;210:1071-7.
15. 2-macroglobulin. J Biol Chem 1981;256:8134-9.
16. 2-macroglobulin molecule. Biochem J 1979;181:401-18.
17. 2-macroglobulin. Immunol Today 1990;11:163-6.
18. 2-macroglobulin. Am J Pathol 1991:138:265-72.
19. 2-macroglobulin. Arch Biochem Biophys 1998;15:192-8.
20. 20. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
21. 21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
22. 2-macroglobulin in multiple sclerosis. Clin Chim Acta 1982;121:167-72.